Clopidogrel: Difference between revisions
(→Common) |
|||
| Line 36: | Line 36: | ||
===Common=== | ===Common=== | ||
*bleeding | |||
*pruritus | |||
==Pharmacology== | ==Pharmacology== | ||
Revision as of 23:08, 26 June 2015
General
- Type: Antiplatelet
- Dosage Forms: 75, 300 PO
- Common Trade Names: Plavix
Adult Dosing
Pediatric Dosing
Special Populations
- Pregnancy Rating:
- Lactation:
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- bleeding, severe,
- hemorrhage
- TTP
- agranulocytosis
- hypersensitivity rxn
- anaphylactoid rxn
- Stevens-Johnson syndrome
- toxic epidermal necrolysis
- erythema multiforme
- drug rash w/ eosinophilia and systemic sx
- pneumonia, eosinophilic
Common
- bleeding
- pruritus
Pharmacology
- Half-life: 8h
- Metabolism: liver, CYP450: 1A2, 2C9, 2C19 (primary), 3A4 substrate
- Excretion: urine 50%, feces 46%
- Mechanism of Action: irreversibly binds to P2Y12 adenosine diphosphate receptors, reducing platelet activation and aggregation
